Mars launches landmark global study program on pets’ contribution to human wellbeing
Mars announces intention to undertake world's largest international study program into the human-animal bond and the role of cats and dogs in human mental health and wellbeing The multi-year research program in partnership with leading academics will span over 35,000 people across more than 20 countries. It launches at a time...
Bestqool Unveils Four-Wavelength Pro Series and Second-Gen Mobile Stand at Original Price
NEW YORK, Feb. 21, 2025 /PRNewswire/ -- In a recent announcement, Bestqool is upgrading both the Pro100 and Pro200 to the four-wavelength configuration (630 nm, 660 nm, 850 nm, 940 nm) as the Pro 300, without increasing the price. Apart from this upgrade, Bestqool has also introduced a second-gen light mobile stand that is more controllable and powerful than its predecessor. ...
FIRST AND ONLY TREATMENT FOR CHRONIC HYPOPARATHYROIDISM APPROVED IN AUSTRALIA
YORVIPATH® (palopegteriparatide) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of chronic hypoparathyroidism in adults1 First-in-class novel PTH replacement therapy Australia becomes the first country to obtain Marketing Authorisation for YORVIPATH since FDA approval SINGAPORE, Feb. 21, 2025 /PRNewswire/ -- Independent biopharmaceutical company Specialised Therapeutics (ST) welcomes...
NAVER D2SF-Backed PranaQ® Receives FDA 510(k) Clearance for TipTraQ, an AI-Enabled Home Sleep Apnea Test
SEOUL, South Korea, Feb. 21, 2025 /PRNewswire/ -- PranaQ, backed by NAVER D2SF continues to push the boundaries of AI-powered healthcare solutions. NAVER D2SF, NAVER's corporate venturing arm, actively collaborates with startups to drive innovation and sustainable growth. This investment underscores NAVER D2SF's commitment to advancing AI and healthcare technologies on a global scale. PranaQ, a pioneer in AI-powered...
Corti Collaborates with Wolters Kluwer to Bring UpToDate’s Trusted Clinical Content to its Specialized AI Platform
Clinicians can now access evidence-based clinical content live during consultations via the Corti Assistant app NEW YORK, Feb. 20, 2025 /PRNewswire/ -- Corti, the leading AI and research company in healthcare, today announced it is collaborating with Wolters Kluwer Health to integrate its market-leading clinical decision support solution, UpToDate®, into Corti's real-time AI platform,...
Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion
MELBOURNE, Australia and INDIANAPOLIS, Ind., Feb. 20, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces its financial results for the year ended 31 December 2024. All figures are in AU$ unless stated otherwise. FY2024 highlights Total revenue, driven primarily from sales of Illuccix® of $783.2 million, up by 56%1...
111 to Announce Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results on March 20, 2025 – Conference Call to Follow
SHANGHAI, Feb. 20, 2025 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2024 ended December 31,...
Hong Kong Pharma Digital Technology Holdings Limited Partners with Leading Chinese E-commerce Platform to Enhance Cross-Border Logistics Services
NEW YORK, Feb. 20, 2025 /PRNewswire/ -- Hong Kong Pharma Digital Technology Holdings Limited has recently signed a cooperation agreement with a leading technology-driven e-commerce platform serving hundreds of millions of consumers. This partnership aims to revolutionize cross-border logistics services and enhance the overall customer experience. Hong Kong Pharma Digital Technology Holdings Limited Partners with...
Harbour BioMed and Insilico Medicine Achieve Strategic Collaboration to Advance AI-Driven Antibody Discovery and Development
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Feb. 20, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immunology and oncology, and Insilico Medicine ("Insilico"), a clinical stage generative artificial intelligence (AI)-driven biotechnology company, today announced...
Check PD: New Parkinson’s Screening App with 90% Accuracy–Download Now!
BANGKOK, Feb. 20, 2025 /PRNewswire/ -- King Chulalongkorn Memorial Hospital and Thai Red Cross Society have launched the "Check PD" application for Parkinson's risk screening after statistics show that the disease rate among Thai people has increased and is found in individuals under 60 years old. The application boasts an accuracy rate of screening at 90%. Thai people, especially those 40 years and above,...
